The House of Representatives voted Thursday to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare. The vote was 232-193, with 12 Republican members joining their Democratic colleagues to pass the measure.
The Affordable Insulin Now Act would cap insulin prices at either $35 a month or 25% of an insurance plan’s negotiated price — whichever is lower. The legislation aims to take effect in 2023 but its fate in the Senate remains unclear.
“This is a kitchen table issue, “House Speaker Nancy Pelosi, D-Calif., said to reporters ahead of the bill’s passage on Thursday.
Read this story and all our reporting for free — forever.
Sign up for our newsletter to support WABE’s mission of delivering independent, in-depth journalism — and hand-picked NPR stories that matter to Atlanta.
We will never share your email address with others. How does your newsletter sign-up support WABE and Public Media...
